Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.7, Iss.8, 2006-12, pp. : 1185-1198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cells, cytokines and cellular immunity in the pathogenesis of fibroproliferative vasculopathies

By Mitra Amit K Del Core Michael G Agrawal Devendra K

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 8-9, 2005-08 ,pp. : 701-715

NRC Research Press

Access to resources Recommend Favorite

Gene Therapy: The First Approved Gene-Based Medicines, Molecular Mechanisms and Clinical Indications

Current Molecular Pharmacology, Vol. 1, Iss. 1, 2008-01 ,pp. : 13-23

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy for Restenosis: Current Status

By Rutanen J.

Drugs, Vol. 62, Iss. 11, 2002-01 ,pp. : 1575-1585

Adis International

Access to resources Recommend Favorite

Current Advances in Retroviral Gene Therapy

Current Gene Therapy, Vol. 11, Iss. 3, 2011-06 ,pp. : 218-228

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Mechanisms of Cholangiocarcinogenesis: New Potential Targets for Therapy

Current Drug Targets, Vol. 18, Iss. 8, 2017-05 ,pp. : 932-949

Bentham Science Publishers

Access to resources Recommend Favorite